Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.
Sign Up to like & getrecommendations! Published in 2018 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2018.06.017
Abstract: PURPOSE To evaluate the effectiveness and safety of oral memantine as a potential neuroprotective agent in open-angle glaucoma (OAG) at risk for progression. DESIGN Two randomized, double-masked, placebo-controlled, parallel-group, multicenter, 48-month studies identically designed, initiated… read more here.
Keywords: glaucomatous progression; treatment; optic disc; placebo ... See more keywords
Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2022.10.08
Abstract: AIM To investigate whether pretreatment with pressure-lowering medication prior to anti-vascular endothelial factor (VEGF) injections had an effect on glaucomatous progression in patients with preexisting glaucoma or ocular hypertension (OHT). METHODS A total of 66… read more here.
Keywords: pressure lowering; glaucomatous progression; progression patients; lowering medication ... See more keywords